Inflammation and immunology of the vitreoretinal compartment

Inflammation and Allergy - Drug Targets

Volumn 10, Issue 4, 2011, Pages 283-309

  Boehm, Michael R R ^a,b   Oellers, Patrick ^a   Thanos, Solon ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b Interdisciplinary Center for Clinical Research   (Germany)

Author keywords

Age related macular degeneration; Aging retina; Complement system; Cytokines; Diabetic retinopathy; Glaucoma; Immune system; Uveitis

Indexed keywords

CYCLOOXYGENASE 2; FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADAPTIVE IMMUNITY; B LYMPHOCYTE; BLOOD BRAIN BARRIER; BLOOD RETINA BARRIER; CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; COMPLEMENT SYSTEM; DENDRITIC CELL; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE SEVERITY; GLAUCOMA; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; IMMUNOLOGY; IMMUNOSURVEILLANCE; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; MICROGLIA; NERVE DEGENERATION; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; RETINA; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; T LYMPHOCYTE; UVEITIS; VITREORETINAL COMPARTMENT; VITREOUS DISEASE;

EID: 79959956948     PISSN: 18715281     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152811796117717     Document Type: Review

References (442)

1. Page, A. R.; Good, R. A. A clinical and experimental study of the function of neutrophils in the inflammatory response. Am. J. Pathol., 1958, 34, 645-669.
2. Leibovich, S. J.; Ross, R. The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. Am. J. Pathol., 1975, 78, 71-100.
3. Knighton, D.R.; Fliegel V.D. In: Perspectives in Shock Research: Metabolism, Mediators and Models; John C. Passmore, Eds.; Alan R. Liss Inc. V: New York, 1989; pp. 311-320
4. Xu, H.; Chen, M.; Forrester, J. V. Para-inflammation in the aging retina. Prog. Retin. Eye Res., 2009, 28, 348-368.
5. Medzhitov, R.; Janeway, C., Jr Innate immune recognition: mechanisms and pathways. Immunol. Rev., 2000, 173, 89-97.
6. Medzhitov, R. Origin and physiological roles of inflammation. Nature, 2008, 454, 428-435.
7. Janeway, C. A., Jr Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb. Symp. Quant. Biol., 1989, 54 Pt 1, 1-13.
8. Karre, K.; Ljunggren, H. G.; Piontek, G.; Kiessling, R. Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy. Nature, 1986, 319, 675-678.
9. Austen, K. F.; Fearon, D. T. A molecular basis of activation of the alternative pathway of human complement. Adv. Exp. Med. Biol., 1979, 120B, 3-17.
10. Savill, J.; Fadok, V. Corpse clearance defines the meaning of cell death. Nature, 2000, 407, 784-788.
11. Matzinger, P. The danger model: a renewed sense of self. Science, 2002, 296, 301-305.
12. Oppenheim, J. J.; Yang, D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol., 2005, 17, 359-365.
13. Plata-Salaman, C. R. Immunoregulators in the nervous system. Neurosci. Biobehav. Rev., 1991, 15, 185-215.
14. Markiewski, M. M.; Lambris, J. D. The role of complement in inflammatory diseases from behind the scenes into the spotlight. Am. J. Pathol., 2007, 171, 715-727.
15. Mastellos, D.; Morikis, D.; Isaacs, S. N.; Holland, M. C.; Strey, C. W.; Lambris, J. D. Complement: structure, functions, evolution, and viral molecular mimicry. Immunol. Res., 2003, 27, 367-386.
16. Walport, M. J. Complement. First of two parts. N. Engl. J. Med., 2001, 344, 1058-1066.
17. Vogt, W.; Damerau, B.; Luhmann, B.; Hesse, D.; Haller, Y. Complement activation in human lymph: modulation by the contact activation system and by leukocytes. Int. Arch. Allergy Appl. Immunol., 1986, 79, 423-433.
18. Wiggins, R. C.; Giclas, P. C.; Henson, P. M. Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit. J. Exp. Med., 1981, 153, 1391-1404.
19. Anderson, D.H.; Radeke, M.J.; Gallo, N.B.; Chapin, E.A.; Johnson, P.T.; Curletti, C.R.; Hancox, L.S.; Hu, J.; Ebright, J.N.; Malek, G.; Hauser, M.A.; Rickman, C.B.; Bok, D.; Hageman, G.S.; Johnson, L.V. The pivotal role of the complement system in aging and agerelated macular degeneration: hypothesis re-visited. Prog. Retin. Eye Res., 2010, 29, 95-112.
20. Lee, D. M.; Friend, D. S.; Gurish, M. F.; Benoist, C.; Mathis, D.; Brenner, M. B. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science, 2002, 297, 1689-1692.
21. Clancy, R. M.; Dahinden, C. A.; Hugli, T. E. Complementmediated arachidonate metabolism. Prog. Biochem. Pharmacol., 1985, 20, 120-131.
22. Albrecht, E.A.; Chinnaiyan, A.M.; Varambally, S.; Kumar-Sinha, C.; Barrette, T.R.; Sarma, J.V.; Ward, P.A. C5a-induced gene expression in human umbilical vein endothelial cells. Am. J. Pathol., 2004, 164, 849-859.
23. DiScipio, R. G.; Daffern, P. J.; Jagels, M. A.; Broide, D. H.; Sriramarao, P. A comparison of C3a and C5a-mediated stable adhesion of rolling eosinophils in postcapillary venules and transendothelial migration in vitro and in vivo. J. Immunol., 1999, 162, 1127-1136.
24. Burke-Gaffney, A.; Blease, K.; Hartnell, A.; Hellewell, P. G. TNFalpha potentiates C5a-stimulated eosinophil adhesion to human bronchial epithelial cells: a role for alpha 5 beta 1 integrin. J. Immunol., 2002, 168, 1380-1388.
25. Walport, M. J. Complement. Second of two parts. N. Engl. J. Med., 2001, 344, 1140-1144.
26. Kohl, J. Self, non-self, and danger: a complementary view. Adv. Exp. Med. Biol., 2006, 586, 71-94.
27. di Giovine, F. S.; Duff, G. W. Interleukin 1: the first interleukin. Immunol. Today, 1990, 11, 13-20.
28. Le, J. M.; Vilcek, J. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab. Invest., 1989, 61, 588-602.
29. Van der Meer, J. W.; Helle, M.; Aarden, L. Comparison of the effects of recombinant interleukin 6 and recombinant interleukin 1 on nonspecific resistance to infection. Eur. J. Immunol., 1989, 19, 413-416.
30. Baggiolini, M.; Walz, A.; Kunkel, S. L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J. Clin. Invest., 1989, 84, 1045-1049.
31. Strieter, R.M.; Kunkel, S.L.; Elner, V.M.; Martonyi, C.L.; Koch, A.E.; Polverini, P.J.; Elner, S.G. Interleukin-8. A corneal factor that induces neovascularization. Am. J. Pathol., 1992, 141, 1279-1284.
32. Kirman, I.; Vainer, B.; Nielsen, O. H. Interleukin-15 and its role in chronic inflammatory diseases. Inflamm. Res., 1998, 47, 285-289.
33. Baggiolini, M.; Dahinden, C. A. CC chemokines in allergic inflammation. Immunol. Today, 1994, 15, 127-133.
34. Holtkamp, G. M.; Kijlstra, A.; Peek, R.; de Vos, A. F. Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes. Prog. Retin. Eye Res., 2001, 20, 29-48.
35. Matsushima, K.; Larsen, C. G.; DuBois, G. C.; Oppenheim, J. J. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J. Exp. Med., 1989, 169, 1485-1490.
36. Taub, D.D.; Proost, P.; Murphy, W.J.; Anver, M.; Longo, D.L.; van Damme, J.; Oppenheim, J.J. Monocyte chemotactic protein-1 (MCP-1),-2, and-3 are chemotactic for human T lymphocytes. J. Clin. Invest., 1995, 95, 1370-1376.
37. Beutler, B.; Cerami, A. The biology of cachectin/TNF--a primary mediator of the host response. Annu. Rev. Immunol., 1989, 7, 625-655.
38. Wahl, S. M.; McCartney-Francis, N.; Mergenhagen, S. E. Inflammatory and immunomodulatory roles of TGF-beta. Immunol. Today, 1989, 10, 258-261.
39. Roberts, W. G.; Palade, G. E. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. J. Cell. Sci., 1995, 108 (Pt 6), 2369-2379.
40. Ruef, C.; Coleman, D. L. Granulocyte-macrophage colonystimulating factor: pleiotropic cytokine with potential clinical usefulness. Rev. Infect. Dis., 1990, 12, 41-62.
41. Aloe, L.; Bracci-Laudiero, L.; Bonini, S.; Manni, L. The expanding role of nerve growth factor: from neurotrophic activity to immunologic diseases. Allergy, 1997, 52, 883-894.
42. Gospodarowicz, D.; Neufeld, G.; Schweigerer, L. Fibroblast growth factor. Mol. Cell. Endocrinol., 1986, 46, 187-204.
43. Humbel, R. E. Insulin-like growth factors I and II. Eur. J. Biochem., 1990, 190, 445-462.
44. Nathan, C.; Xie, Q. W. Regulation of biosynthesis of nitric oxide. J. Biol. Chem., 1994, 269, 13725-13728.
45. Moncada, S.; Higgs, E. A. Endogenous nitric oxide: physiology, pathology and clinical relevance. Eur. J. Clin. Invest., 1991, 21, 361-374.
46. Nathan, C.; Xie, Q. W. Nitric oxide synthases: roles, tolls, and controls. Cell, 1994, 78, 915-918.
47. Nussler, A. K.; Billiar, T. R. Inflammation, immunoregulation, and inducible nitric oxide synthase. J. Leukoc. Biol., 1993, 54, 171-178.
48. Perry, V. H.; Andersson, P. B.; Gordon, S. Macrophages and inflammation in the central nervous system. Trends Neurosci., 1993, 16, 268-273.
49. Schachner, M.; Sidman, R. L. Distribution of H-2 alloantigen in adult and developing mouse brain. Brain Res., 1973, 60, 191-198.
50. Pizarro, O.; Hoecker, G.; Rubinstein, P.; Ramos, A. The distribution in the tissues and the development of H-2 antigens of the mouse. Proc. Natl. Acad. Sci. U. S. A., 1961, 47, 1900-1907.
51. Wong, G. H.; Bartlett, P. F.; Clark-Lewis, I.; McKimm-Breschkin, J. L.; Schrader, J. W. Interferon-gamma induces the expression of H-2 and Ia antigens on brain cells. J. Neuroimmunol., 1985, 7, 255-278.
52. Risau, W.; Engelhardt, B.; Wekerle, H. Immune function of the blood-brain barrier: incomplete presentation of protein (auto-)antigens by rat brain microvascular endothelium in vitro. J. Cell Biol., 1990, 110, 1757-1766.
53. Xu, H.; Chen, M.; Mayer, E. J.; Forrester, J. V.; Dick, A. D. Turnover of resident retinal microglia in the normal adult mouse. Glia, 2007, 55, 1189-1198.
54. HAYREH, S. S. The Cilio-Retinal Arteries. Br. J. Ophthalmol., 1963, 47, 71-89.
55. Rungger-Brandle, E.; Messerli, J. M.; Niemeyer, G.; Eppenberger, H. M. Confocal microscopy and computer-assisted image reconstruction of astrocytes in the mammalian retina. Eur. J. Neurosci., 1993, 5, 1093-1106.
56. Pournaras, C. J.; Rungger-Brandle, E.; Riva, C. E.; Hardarson, S. H.; Stefansson, E. Regulation of retinal blood flow in health and disease. Prog. Retin. Eye Res., 2008, 27, 284-330.
57. Streit, W. J.; Graeber, M. B.; Kreutzberg, G. W. Functional plasticity of microglia: a review. Glia, 1988, 1, 301-307.
58. Perry, V. H.; Gordon, S. Macrophages and microglia in the nervous system. Trends Neurosci., 1988, 11, 273-277.
59. Barron, K. D. The microglial cell. A historical review. J. Neurol. Sci., 1995, 134 (Suppl), 57-68.
60. Hume, D. A.; Perry, V. H.; Gordon, S. Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J. Cell Biol., 1983, 97, 253-257.
61. Bodeutsch, N.; Thanos, S. Migration of phagocytotic cells and development of the murine intraretinal microglial network: an in vivo study using fluorescent dyes. Glia, 2000, 32, 91-101.
62. Langmann, T. Microglia activation in retinal degeneration. J. Leukoc. Biol., 2007, 81, 1345-1351.
63. Sievers, J.; Schmidtmayer, J.; Parwaresch, R. Blood monocytes and spleen macrophages differentiate into microglia-like cells when cultured on astrocytes. Ann. Anat., 1994, 176, 45-51.
64. Perry, V. H.; Andersson, P. B.; Gordon, S. Macrophages and inflammation in the central nervous system. Trends Neurosci., 1993, 16, 268-273.
65. Thanos, S. Sick photoreceptors attract activated microglia from the ganglion cell layer: a model to study the inflammatory cascades in rats with inherited retinal dystrophy. Brain Res., 1992, 588, 21-28.
66. Hanisch, U. K.; Kettenmann, H. Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci., 2007, 10, 1387-1394.
67. Dick, A.D.; Carter, D.; Robertson, M.; Broderick, C.; Hughes, E.; Forrester, J.V.; Liversidge, J. Control of myeloid activity during retinal inflammation. J. Leukoc. Biol., 2003, 74, 161-166.
68. Karlstetter, M.; Ebert, S.; Langmann, T. Microglia in the healthy and degenerating retina: insights from novel mouse models. Immunobiology, 2010, 215, 685-691.
69. Schuetz, E.; Thanos, S. Microglia-targeted pharmacotherapy in retinal neurodegenerative diseases. Curr. Drug Targets, 2004, 5, 619-627.
70. Carwile, M. E.; Culbert, R. B.; Sturdivant, R. L.; Kraft, T. W. Rod outer segment maintenance is enhanced in the presence of bFGF, CNTF and GDNF. Exp. Eye Res., 1998, 66, 791-805.
71. Cardona, A.E.; Pioro, E.P.; Sasse, M.E.; Kostenko, V.; Cardona, S.M.; Dijkstra, I.M.; Huang, D.; Kidd, G.; Dombrowski, S.; Dutta, R.; Lee, J.C.; Cook, D.N.; Jung, S.; Lira, S.A.; Littman, D.R.; Ransohoff, R.M. Control of microglial neurotoxicity by the fractalkine receptor. Nat. Neurosci., 2006, 9, 917-924.
72. Lehrmann, E.; Kiefer, R.; Christensen, T.; Toyka, K.V.; Zimmer, J.; Diemer, N.H.; Hartung, H.P.; Finsen, B. Microglia and macrophages are major sources of locally produced transforming growth factor-beta1 after transient middle cerebral artery occlusion in rats. Glia, 1998, 24, 437-448.
73. Nakamura, Y. Regulating factors for microglial activation. Biol. Pharm. Bull., 2002, 25, 945-953.
74. Mitrasinovic, O. M.; Perez, G. V.; Zhao, F.; Lee, Y. L.; Poon, C.; Murphy, G. M., Jr Overexpression of macrophage colonystimulating factor receptor on microglial cells induces an inflammatory response. J. Biol. Chem., 2001, 276, 30142-30149.
75. Hoek, R.M.; Ruuls, S.R.; Murphy, C.A.; Wright, G.J.; Goddard, R.; Zurawski, S.M.; Blom, B.; Homola, M.E.; Streit, W.J.; Brown, M.H.; Barclay, A.N.; Sedgwick, J.D. Down-regulation of the macrophage lineage through interaction with OX2 (CD200). Science, 2000, 290, 1768-1771.
76. Haynes, S.E.; Hollopeter, G.; Yang, G.; Kurpius, D.; Dailey, M.E.; Gan, W.B.; Julius, D. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci., 2006, 9, 1512-1519.
77. Fries, J. E.; Wheeler-Schilling, T. H.; Guenther, E.; Kohler, K. Expression of P2Y1, P2Y2, P2Y4, and P2Y6 receptor subtypes in the rat retina. Invest. Ophthalmol. Vis. Sci., 2004, 45, 3410-3417.
78. Lee, J. E.; Liang, K. J.; Fariss, R. N.; Wong, W. T. Ex vivo dynamic imaging of retinal microglia using time-lapse confocal microscopy. Invest. Ophthalmol. Vis. Sci., 2008, 49, 4169-4176.
79. Zeng, H. Y.; Zhu, X. A.; Zhang, C.; Yang, L. P.; Wu, L. M.; Tso, M. O. Identification of sequential events and factors associated with microglial activation, migration, and cytotoxicity in retinal degeneration in rd mice. Invest. Ophthalmol. Vis. Sci., 2005, 46, 2992-2999.
80. Lobov, I.B.; Rao, S.; Carroll, T.J.; Vallance, J.E.; Ito, M.; Ondr, J.K.; Kurup, S.; Glass, D.A.; Patel, M.S.; Shu, W.; Morrisey, E.E.; McMahon, A.P.; Karsenty, G.; Lang, R.A. WNT7b mediates macrophage-induced programmed cell death in patterning of the vasculature. Nature, 2005, 437, 417-421.
81. Frade, J. M.; Barde, Y. A. Microglia-derived nerve growth factor causes cell death in the developing retina. Neuron, 1998, 20, 35-41.
82. Srinivasan, B.; Roque, C. H.; Hempstead, B. L.; Al-Ubaidi, M. R.; Roque, R. S. Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J. Biol. Chem., 2004, 279, 41839-41845.
83. Lehnardt, S.; Massillon, L.; Follett, P.; Jensen, F.E.; Ratan, R.; Rosenberg, P.A.; Volpe, J.J.; Vartanian, T. Activation of innate immunity in the CNS triggers neurodegeneration through a Tolllike receptor 4-dependent pathway. Proc. Natl. Acad. Sci. U. S. A., 2003, 100, 8514-8519.
84. Tanga, F. Y.; Nutile-McMenemy, N.; DeLeo, J. A. The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 5856-5861.
85. Jung, D.Y.; Lee, H.; Jung, B.Y.; Ock, J.; Lee, M.S.; Lee, W.H.; Suk, K. TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J. Immunol., 2005, 174, 6467-6476.
86. Takahashi, K.; Rochford, C. D.; Neumann, H. Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2. J. Exp. Med., 2005, 201, 647-657.
87. Thanos, S.; Kacza, J.; Seeger, J.; Mey, J. Old dyes for new scopes: the phagocytosis-dependent long-term fluorescence labelling of microglial cells in vivo. Trends Neurosci., 1994, 17, 177-182.
88. Klesney-Tait, J.; Turnbull, I. R.; Colonna, M. The TREM receptor family and signal integration. Nat. Immunol., 2006, 7, 1266-1273.
89. Husemann, J.; Loike, J. D.; Anankov, R.; Febbraio, M.; Silverstein, S. C. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia, 2002, 40, 195-205.
90. Kindzelskii, A. L.; Elner, V. M.; Elner, S. G.; Yang, D.; Hughes, B. A.; Petty, H. R. Toll-like receptor 4 (TLR4) of retinal pigment epithelial cells participates in transmembrane signaling in response to photoreceptor outer segments. J. Gen. Physiol., 2004, 124, 139-149.
91. Cunha-Vaz, J. The blood-ocular barriers. Surv. Ophthalmol., 1979, 23, 279-296.
92. Risau, W.; Wolburg, H. Development of the blood-brain barrier. Trends Neurosci., 1990, 13, 174-178.
93. Van Itallie, C. M.; Anderson, J. M. The molecular physiology of tight junction pores. Physiology (Bethesda), 2004, 19, 331-338.
94. Hosoya, K.; Yamamoto, A.; Akanuma, S.; Tachikawa, M. Lipophilicity and transporter influence on blood-retinal barrier permeability: a comparison with blood-brain barrier permeability. Pharm. Res., 2010, 27, 2715-2724.
95. Gouverneur, M.; Berg, B.; Nieuwdorp, M.; Stroes, E.; Vink, H. Vasculoprotective properties of the endothelial glycocalyx: effects of fluid shear stress. J. Intern. Med., 2006, 259, 393-400.
96. Runkle, E. A.; Antonetti, D. A. The blood-retinal barrier: structure and functional significance. Methods Mol. Biol., 2011, 686, 133-148.
97. Strauss, O. The retinal pigment epithelium in visual function. Physiol. Rev., 2005, 85, 845-881.
98. Bok, D. The retinal pigment epithelium: a versatile partner in vision. J. Cell Sci. Suppl., 1993, 17, 189-195.
99. Boulton, M.; Dayhaw-Barker, P. The role of the retinal pigment epithelium: topographical variation and ageing changes. Eye (Lond), 2001, 15, 384-389.
100. Beatty, S.; Boulton, M.; Henson, D.; Koh, H. H.; Murray, I. J. Macular pigment and age related macular degeneration. Br. J. Ophthalmol., 1999, 83, 867-877.
101. Beatty, S.; Koh, H.; Phil, M.; Henson, D.; Boulton, M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol., 2000, 45, 115-134.
102. Beatty, S.; Murray, I. J.; Henson, D. B.; Carden, D.; Koh, H.; Boulton, M. E. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest. Ophthalmol. Vis. Sci., 2001, 42, 439-446.
103. Miceli, M. V.; Liles, M. R.; Newsome, D. A. Evaluation of oxidative processes in human pigment epithelial cells associated with retinal outer segment phagocytosis. Exp. Cell Res., 1994, 214, 242-249.
104. Dornonville de la Cour, M. Ion transport in the retinal pigment epithelium. A study with double barrelled ion-selective microelectrodes. Acta Ophthalmol. Suppl., 1993, (209), 1-32.
105. Steinberg, R. H.; Linsenmeier, R. A.; Griff, E. R. Three lightevoked responses of the retinal pigment epithelium. Vision Res., 1983, 23, 1315-1323.
106. Steinberg, R. H. Interactions between the retinal pigment epithelium and the neural retina. Doc. Ophthalmol., 1985, 60, 327-346.
107. Young, R. W. Shedding of discs from rod outer segments in the rhesus monkey. J. Ultrastruct. Res., 1971, 34, 190-203.
108. Adler, A. J.; Southwick, R. E. Distribution of glucose and lactate in the interphotoreceptor matrix. Ophthalmic Res., 1992, 24, 243-252.
109. Padnick-Silver, L.; Linsenmeier, R. A. Quantification of in vivo anaerobic metabolism in the normal cat retina through intraretinal pH measurements. Vis. Neurosci., 2002, 19, 793-806.
110. Bergersen, L.; Jóhannsson, E.; Veruki, M.L.; Nagelhus, E.A.; Halestrap, A.; Sejersted, O.M.; Ottersen, O.P. Cellular and subcellular expression of monocarboxylate transporters in the pigment epithelium and retina of the rat. Neuroscience, 1999, 90, 319-331.
111. Philp, N. J.; Yoon, H.; Grollman, E. F. Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE. Am. J. Physiol., 1998, 274, R1824-8.
112. Kenyon, E.; Yu, K.; La Cour, M.; Miller, S. S. Lactate transport mechanisms at apical and basolateral membranes of bovine retinal pigment epithelium. Am. J. Physiol., 1994, 267, C1561-73.
113. Hamann, S.; Zeuthen, T.; La Cour, M.; Nagelhus, E.A.; Ottersen, O.P.; Agre, P.; Nielsen, S. Aquaporins in complex tissues: distribution of aquaporins 1-5 in human and rat eye. Am. J. Physiol., 1998, 274, C1332-45.
114. Marmor, M. F. Control of subretinal fluid: experimental and clinical studies. Eye (Lond), 1990, 4 (Pt 2), 340-344.
115. Marmor, M. F. Mechanisms of fluid accumulation in retinal edema. Doc. Ophthalmol., 1999, 97, 239-249.
116. Moseley, H.; Foulds, W. S.; Allan, D.; Kyle, P. M. Routes of clearance of radioactive water from the rabbit vitreous. Br. J. Ophthalmol., 1984, 68, 145-151.
117. Stamer, W. D.; Bok, D.; Hu, J.; Jaffe, G. J.; McKay, B. S. Aquaporin-1 channels in human retinal pigment epithelium: role in transepithelial water movement. Invest. Ophthalmol. Vis. Sci., 2003, 44, 2803-2808.
118. Ammar, D. A.; Hughes, B. A.; Thompson, D. A. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses. Invest. Ophthalmol. Vis. Sci., 1998, 39, 1870-1878.
119. Beitz, E.; Volkel, H.; Guo, Y.; Schultz, J. E. Adenylyl cyclase type 7 is the predominant isoform in the bovine retinal pigment epithelium. Acta Anat. (Basel), 1998, 162, 157-162.
120. Joseph, D. P.; Miller, S. S. Alpha-1-adrenergic modulation of K and Cl transport in bovine retinal pigment epithelium. J. Gen. Physiol., 1992, 99, 263-290.
121. Quinn, R. H.; Quong, J. N.; Miller, S. S. Adrenergic receptor activated ion transport in human fetal retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci., 2001, 42, 255-264.
122. Rymer, J.; Miller, S. S.; Edelman, J. L. Epinephrine-induced increases in [Ca2+](in) and KCl-coupled fluid absorption in bovine RPE. Invest. Ophthalmol. Vis. Sci., 2001, 42, 1921-1929.
123. Maminishkis, A.; Jalickee, S.; Blaug, S.A.; Rymer, J.; Yerxa, B.R.; Peterson, W.M.; Miller, S.S. The P2Y(2) receptor agonist INS37217 stimulates RPE fluid transport in vitro and retinal reattachment in rat. Invest. Ophthalmol. Vis. Sci., 2002, 43, 3555-3566.
124. Mitchell, C. H. Release of ATP by a human retinal pigment epithelial cell line: potential for autocrine stimulation through subretinal space. J. Physiol., 2001, 534, 193-202.
125. Ryan, J. S.; Baldridge, W. H.; Kelly, M. E. Purinergic regulation of cation conductances and intracellular Ca2+ in cultured rat retinal pigment epithelial cells. J. Physiol., 1999, 520 Pt 3, 745-759.
126. Witmer, A. N.; Vrensen, G. F.; Van Noorden, C. J.; Schlingemann, R. O. Vascular endothelial growth factors and angiogenesis in eye disease. Prog. Retin. Eye Res., 2003, 22, 1-29.
127. Cao, W.; Wen, R.; Li, F.; Lavail, M. M.; Steinberg, R. H. Mechanical injury increases bFGF and CNTF mRNA expression in the mouse retina. Exp. Eye Res., 1997, 65, 241-248.
128. Steele, F. R.; Chader, G. J.; Johnson, L. V.; Tombran-Tink, J. Pigment epithelium-derived factor: neurotrophic activity and identification as a member of the serine protease inhibitor gene family. Proc. Natl. Acad. Sci. U. S. A., 1993, 90, 1526-1530.
129. Cao, W.; Tombran-Tink, J.; Elias, R.; Sezate, S.; Mrazek, D.; McGinnis, J. F. In vivo protection of photoreceptors from light damage by pigment epithelium-derived factor. Invest. Ophthalmol. Vis. Sci., 2001, 42, 1646-1652.
130. Ogata, N.; Wang, L.; Jo, N.; Tombran-Tink, J.; Takahashi, K.; Mrazek, D.; Matsumura, M. Pigment epithelium derived factor as a neuroprotective agent against ischemic retinal injury. Curr. Eye Res., 2001, 22, 245-252.
131. Adamis, A.P.; Shima, D.T.; Yeo, K.T.; Yeo, T.K.; Brown, L.F.; Berse, B.; D'Amore, P.A.; Folkman, J. Synthesis and secretion of vascular permeability factor/vascular endothelial growth factor by human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun., 1993, 193, 631-638.
132. Lopez, P. F.; Sippy, B. D.; Lambert, H. M.; Thach, A. B.; Hinton, D. R. Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest. Ophthalmol. Vis. Sci., 1996, 37, 855-868.
133. Burns, M. S.; Hartz, M. J. The retinal pigment epithelium induces fenestration of endothelial cells in vivo. Curr. Eye Res., 1992, 11, 863-873.
134. Blanco, R. E.; Lopez-Roca, A.; Soto, J.; Blagburn, J. M. Basic fibroblast growth factor applied to the optic nerve after injury increases long-term cell survival in the frog retina. J. Comp. Neurol., 2000, 423, 646-658.
135. Wen, R.; Song, Y.; Cheng, T.; Matthes, M.T.; Yasumura, D.; LaVail, M.M.; Steinberg, R.H. Injury-induced upregulation of bFGF and CNTF mRNAS in the rat retina. J. Neurosci., 1995, 15, 7377-7385.
136. Grimm, C.; Wenzel, A.; Williams, T.; Rol, P.; Hafezi, F.; Reme, C. Rhodopsin-mediated blue-light damage to the rat retina: effect of photoreversal of bleaching. Invest. Ophthalmol. Vis. Sci., 2001, 42, 497-505.
137. Hafezi, F.; Steinbach, J.P.; Marti, A.; Munz, K.; Wang, Z.Q.; Wagner, E.F.; Aguzzi, A.; Remé, C.E. The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. Nat. Med., 1997, 3, 346-349.
138. Iseli, H. P.; Wenzel, A.; Hafezi, F.; Reme, C. E.; Grimm, C. Light damage susceptibility and RPE65 in rats. Exp. Eye Res., 2002, 75, 407-413.
139. Streilein, J. W.; Ma, N.; Wenkel, H.; Ng, T. F.; Zamiri, P. Immunobiology and privilege of neuronal retina and pigment epithelium transplants. Vision Res., 2002, 42, 487-495.
140. Detrick, B.; Hooks, J. J. Immune regulation in the retina. Immunol. Res., 2010, 47, 153-161.
141. Johnson, L. V.; Leitner, W. P.; Staples, M. K.; Anderson, D. H. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. Exp. Eye Res., 2001, 73, 887-896.
142. Tenner, A. J.; Volkin, D. B. Complement subcomponent C1q secreted by cultured human monocytes has subunit structure identical with that of serum C1q. Biochem. J., 1986, 233, 451-458.
143. Davis, A. E., 3rd; Cai, S.; Liu, D. C1 inhibitor: biologic activities that are independent of protease inhibition. Immunobiology, 2007, 212, 313-323.
144. Jiang, H.; Wagner, E.; Zhang, H.; Frank, M. M. Complement 1 inhibitor is a regulator of the alternative complement pathway. J. Exp. Med., 2001, 194, 1609-1616.
145. Laine, M.; Jarva, H.; Seitsonen, S.; Haapasalo, K.; Lehtinen, M.J.; Lindeman, N.; Anderson, D.H.; Johnson, P.T.; Järvelä, I.; Jokiranta, T.S.; Hageman, G.S.; Immonen, I.; Meri, S. Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein. J. Immunol., 2007, 178, 3831-3836.
146. Bossi, F.; Rizzi, L.; Bulla, R.; Debeus, A.; Tripodo, C.; Picotti, P.; Betto, E.; Macor, P.; Pucillo, C.; Würzner, R.; Tedesco, F. C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function. Blood, 2009, 113, 3640-3648.
147. Jaffe, G.J.; Van Le, L.; Valea, F.; Haskill, S.; Roberts, W.; Arend, W.P.; Stuart, A.; Peters, W.P. Expression of interleukin-1 alpha, interleukin-1 beta, and an interleukin-1 receptor antagonist in human retinal pigment epithelial cells. Exp. Eye Res., 1992, 55, 325-335.
148. Arend, W. P.; Joslin, F. G.; Thompson, R. C.; Hannum, C. H. An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties. J. Immunol., 1989, 143, 1851-1858.
149. Planck, S. R.; Huang, X. N.; Robertson, J. E.; Rosenbaum, J. T. Retinal pigment epithelial cells produce interleukin-1 beta and granulocyte-macrophage colony-stimulating factor in response to interleukin-1 alpha. Curr. Eye Res., 1993, 12, 205-212.
150. Benson, M. T.; Shepherd, L.; Rees, R. C.; Rennie, I. G. Production of interleukin-6 by human retinal pigment epithelium in vitro and its regulation by other cytokines. Curr. Eye Res., 1992, 11 Suppl, 173-179.
151. Elner, V. M.; Strieter, R. M.; Elner, S. G.; Baggiolini, M.; Lindley, I.; Kunkel, S. L. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am. J. Pathol., 1990, 136, 745-750.
152. Hofmeister, R.; Khaled, A. R.; Benbernou, N.; Rajnavolgyi, E.; Muegge, K.; Durum, S. K. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev., 1999, 10, 41-60.
153. Holtkamp, G. M.; Van Rossem, M.; de Vos, A. F.; Willekens, B.; Peek, R.; Kijlstra, A. Polarized secretion of IL-6 and IL-8 by human retinal pigment epithelial cells. Clin. Exp. Immunol., 1998, 112, 34-43.
154. Jaffe, G. J.; Roberts, W. L.; Wong, H. L.; Yurochko, A. D.; Cianciolo, G. J. Monocyte-induced cytokine expression in cultured human retinal pigment epithelial cells. Exp. Eye Res., 1995, 60, 533-543.
155. Elner, S. G.; Strieter, R. M.; Elner, V. M.; Rollins, B. J.; Del Monte, M. A.; Kunkel, S. L. Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab. Invest., 1991, 64, 819-825.
156. Holtkamp, G. M.; De Vos, A. F.; Peek, R.; Kijlsta, A. Analysis of the secretion pattern of monocyte chemotactic protein-1 (MCP-1) and transforming growth factor-beta 2 (TGF-beta2) by human retinal pigment epithelial cells. Clin. Exp. Immunol., 1999, 118, 35-40.
157. Kurtz, R. M.; Elner, V. M.; Bian, Z. M.; Strieter, R. M.; Kunkel, S. L.; Elner, S. G. Dexamethasone and cyclosporin A modulation of human retinal pigment epithelial cell monocyte chemotactic protein-1 and interleukin-8. Invest. Ophthalmol. Vis. Sci., 1997, 38, 436-445.
158. Crane, I. J.; Kuppner, M. C.; McKillop-Smith, S.; Knott, R. M.; Forrester, J. V. Cytokine regulation of RANTES production by human retinal pigment epithelial cells. Cell. Immunol., 1998, 184, 37-44.
159. Tanihara, H.; Yoshida, M.; Yoshimura, N. Tumor necrosis factoralpha gene is expressed in stimulated retinal pigment epithelial cells in culture. Biochem. Biophys. Res. Commun., 1992, 187, 1029-1034.
160. de Kozak, Y.; Naud, M. C.; Bellot, J.; Faure, J. P.; Hicks, D. Differential tumor necrosis factor expression by resident retinal cells from experimental uveitis-susceptible and-resistant rat strains. J. Neuroimmunol., 1994, 55, 1-9.
161. Tanihara, H.; Yoshida, M.; Matsumoto, M.; Yoshimura, N. Identification of transforming growth factor-beta expressed in cultured human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci., 1993, 34, 413-419.
162. Matsumoto, M.; Yoshimura, N.; Honda, Y. Increased production of transforming growth factor-beta 2 from cultured human retinal pigment epithelial cells by photocoagulation. Invest. Ophthalmol. Vis. Sci., 1994, 35, 4245-4252.
163. Sone, H.; Kawakami, Y.; Okuda, Y.; Kondo, S.; Hanatani, M.; Suzuki, H.; Yamashita, K. Vascular endothelial growth factor is induced by long-term high glucose concentration and up-regulated by acute glucose deprivation in cultured bovine retinal pigmented epithelial cells. Biochem. Biophys. Res. Commun., 1996, 221, 193-198.
164. Jaffe, G.J.; Peters, W.P.; Roberts, W.; Kurtzberg, J.; Stuart, A.; Wang, A.M.; Stoudemire, J.B. Modulation of macrophage colony stimulating factor in cultured human retinal pigment epithelial cells. Exp. Eye Res., 1992, 54, 595-603.
165. Ishida, K.; Yoshimura, N.; Yoshida, M.; Honda, Y.; Murase, K.; Hayashi, K. Expression of neurotrophic factors in cultured human retinal pigment epithelial cells. Curr. Eye Res., 1997, 16, 96-101.
166. Kitaoka, T.; Bost, L. M.; Ishigooka, H.; Aotaki-Keen, A. E.; Hjelmeland, L. M. Increasing cell density down-regulates the expression of acidic FGF by human RPE cells in vitro. Curr. Eye Res., 1993, 12, 993-999.
167. Khaliq, A.; Patel, B.; Jarvis-Evans, J.; Moriarty, P.; McLeod, D.; Boulton, M. Oxygen modulates production of bFGF and TGF-beta by retinal cells in vitro. Exp. Eye Res., 1995, 60, 415-423.
168. Hackett, S. F.; Schoenfeld, C. L.; Freund, J.; Gottsch, J. D.; Bhargave, S.; Campochiaro, P. A. Neurotrophic factors, cytokines and stress increase expression of basic fibroblast growth factor in retinal pigmented epithelial cells. Exp. Eye Res., 1997, 64, 865-873.
169. Guillonneau, X.; Regnier-Ricard, F.; Dupuis, C.; Courtois, Y.; Mascarelli, F. FGF2-stimulated release of endogenous FGF1 is associated with reduced apoptosis in retinal pigmented epithelial cells. Exp. Cell Res., 1997, 233, 198-206.
170. Choudhury, P.; Chen, W.; Hunt, R. C. Production of plateletderived growth factor by interleukin-1 beta and transforming growth factor-beta-stimulated retinal pigment epithelial cells leads to contraction of collagen gels. Invest. Ophthalmol. Vis. Sci., 1997, 38, 824-833.
171. Martin, D. M.; Yee, D.; Feldman, E. L. Gene expression of the insulin-like growth factors and their receptors in cultured human retinal pigment epithelial cells. Brain Res. Mol. Brain Res., 1992, 12, 181-186.
172. Waldbillig, R. J.; Arnold, D. R.; Fletcher, R. T.; Chader, G. J. Insulin and IGF-I binding in developing chick neural retina and pigment epithelium: a characterization of binding and structural differences. Exp. Eye Res., 1991, 53, 13-22.
173. Sparrow, J. R.; Nathan, C.; Vodovotz, Y. Cytokine regulation of nitric oxide synthase in mouse retinal pigment epithelial cells in culture. Exp. Eye Res., 1994, 59, 129-139.
174. Goureau, O.; Lepoivre, M.; Becquet, F.; Courtois, Y. Differential regulation of inducible nitric oxide synthase by fibroblast growth factors and transforming growth factor beta in bovine retinal pigmented epithelial cells: inverse correlation with cellular proliferation. Proc. Natl. Acad. Sci. U. S. A., 1993, 90, 4276-4280.
175. Goureau, O.; Hicks, D.; Courtois, Y. Human retinal pigmented epithelial cells produce nitric oxide in response to cytokines. Biochem. Biophys. Res. Commun., 1994, 198, 120-126.
176. Liversidge, J.; Grabowski, P.; Ralston, S.; Benjamin, N.; Forrester, J. V. Rat retinal pigment epithelial cells express an inducible form of nitric oxide synthase and produce nitric oxide in response to inflammatory cytokines and activated T cells. Immunology, 1994, 83, 404-409.
177. Kutty, R. K.; Kutty, G.; Hooks, J. J.; Wiggert, B.; Nagineni, C. N. Transforming growth factor-beta inhibits the cytokine-mediated expression of the inducible nitric oxide synthase mRNA in human retinal pigment epithelial cells. Biochem. Biophys. Res. Commun., 1995, 215, 386-393.
178. Liversidge, J. M.; Sewell, H. F.; Forrester, J. V. Human retinal pigment epithelial cells differentially express MHC class II (HLA, DP, DR and DQ) antigens in response to in vitro stimulation with lymphokine or purified IFN-gamma. Clin. Exp. Immunol., 1988, 73, 489-494.
179. Percopo, C. M.; Hooks, J. J.; Shinohara, T.; Caspi, R.; Detrick, B. Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. J. Immunol., 1990, 145, 4101-4107.
180. Osusky, R.; Dorio, R. J.; Arora, Y. K.; Ryan, S. J.; Walker, S. M. MHC class II positive retinal pigment epithelial (RPE) cells can function as antigen-presenting cells for microbial superantigen. Ocul. Immunol. Inflamm., 1997, 5, 43-50.
181. Detrick, B.; Newsome, D. A.; Percopo, C. M.; Hooks, J. J. Class II antigen expression and gamma interferon modulation of monocytes and retinal pigment epithelial cells from patients with retinitis pigmentosa. Clin. Immunol. Immunopathol., 1985, 36, 201-211.
182. Chan, C. C.; Detrick, B.; Nussenblatt, R. B.; Palestine, A. G.; Fujikawa, L. S.; Hooks, J. J. HLA-DR antigens on retinal pigment epithelial cells from patients with uveitis. Arch. Ophthalmol., 1986, 104, 725-729.
183. Springer, T. A. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell, 1994, 76, 301-314.
184. Platts, K. E.; Benson, M. T.; Rennie, I. G.; Sharrard, R. M.; Rees, R. C. Cytokine modulation of adhesion molecule expression on human retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci., 1995, 36, 2262-2269.
185. Liversidge, J.; Sewell, H. F.; Forrester, J. V. Interactions between lymphocytes and cells of the blood-retina barrier: mechanisms of T lymphocyte adhesion to human retinal capillary endothelial cells and retinal pigment epithelial cells in vitro. Immunology, 1990, 71, 390-396.
186. Mesri, M.; Liversidge, J.; Forrester, J. V. ICAM-1/LFA-1 interactions in T-lymphocyte activation and adhesion to cells of the blood-retina barrier in the rat. Immunology, 1994, 83, 52-57.
187. Devine, L.; Lightman, S.; Greenwood, J. Lymphocyte migration across the anterior and posterior blood-retinal barrier in vitro. Cell. Immunol., 1996, 168, 267-275.
188. Devine, L.; Lightman, S. L.; Greenwood, J. Role of LFA-1, ICAM-1, VLA-4 and VCAM-1 in lymphocyte migration across retinal pigment epithelial monolayers in vitro. Immunology, 1996, 88, 456-462.
189. Claudio, L.; Martiney, J. A.; Brosnan, C. F. Ultrastructural studies of the blood-retina barrier after exposure to interleukin-1 beta or tumor necrosis factor-alpha. Lab. Invest., 1994, 70, 850-861.
190. Bamforth, S. D.; Lightman, S.; Greenwood, J. The effect of TNFalpha and IL-6 on the permeability of the rat blood-retinal barrier in vivo. Acta Neuropathol., 1996, 91, 624-632.
191. Luna, J.D.; Chan, C.C.; Derevjanik, N.L.; Mahlow, J.; Chiu, C.; Peng, B.; Tobe, T.; Campochiaro, P.A.; Vinores, S.A. Blood-retinal barrier (BRB) breakdown in experimental autoimmune uveoretinitis: comparison with vascular endothelial growth factor, tumor necrosis factor alpha, and interleukin-1beta-mediated breakdown. J. Neurosci. Res., 1997, 49, 268-280.
192. Usui, Y.; Okunuki, Y.; Hattori, T.; Kezuka, T.; Keino, H.; Ebihara, N.; Sugita, S.; Usui, M.; Goto, H.; Takeuchi, M. Functional expression of B7H1 on retinal pigment epithelial cells. Exp. Eye Res., 2008, 86, 52-59.
193. Sugita, S. Role of ocular pigment epithelial cells in immune privilege. Arch. Immunol. Ther. Exp. (Warsz), 2009, 57, 263-268.
194. Sugita, S.; Horie, S.; Nakamura, O.;, Futagami, Y.; Takase, H.; Keino, H.; Aburatani, H.; Katunuma, N.; Ishidoh, K.; Yamamoto, Y.; Mochizuki, M. Retinal pigment epithelium-derived CTLA-2alpha induces TGFbeta-producing T regulatory cells. J. Immunol., 2008, 181, 7525-7536.
195. Muzio, L.; Martino, G.; Furlan, R. Multifaceted aspects of inflammation in multiple sclerosis: the role of microglia. J. Neuroimmunol., 2007, 191, 39-44.
196. Gao, H.; Hollyfield, J. G. Aging of the human retina. Differential loss of neurons and retinal pigment epithelial cells. Invest. Ophthalmol. Vis. Sci., 1992, 33, 1-17.
197. Curcio, C. A.; Millican, C. L.; Allen, K. A.; Kalina, R. E. Aging of the human photoreceptor mosaic: evidence for selective vulnerability of rods in central retina. Invest. Ophthalmol. Vis. Sci., 1993, 34, 3278-3296.
198. Newsome, D. A.; Huh, W.; Green, W. R. Bruch's membrane agerelated changes vary by region. Curr. Eye Res., 1987, 6, 1211-1221.
199. Bird, A. C.; Marshall, J. Retinal pigment epithelial detachments in the elderly. Trans. Ophthalmol. Soc. U. K., 1986, 105 (Pt 6), 674-682.
200. Cheon, E.W.; Park, C.H.; Kang, S.S.; Cho, G.J.; Yoo, J.M.; Song, J.K.; Choi, W.S. Nitric oxide synthase expression in the transient ischemic rat retina: neuroprotection of betaxolol. Neurosci. Lett., 2002, 330, 265-269.
201. Goto, R.; Doi, M.; Ma, N.; Semba, R.; Uji, Y. Contribution of nitric oxide-producing cells in normal and diabetic rat retina. Jpn. J. Ophthalmol., 2005, 49, 363-370.
202. Park, S. H.; Kim, J. H.; Kim, Y. H.; Park, C. K. Expression of neuronal nitric oxide synthase in the retina of a rat model of chronic glaucoma. Vision Res., 2007, 47, 2732-2740.
203. Zhu, Y.; Ohlemiller, K. K.; McMahan, B. K.; Park, T. S.; Gidday, J. M. Constitutive nitric oxide synthase activity is required to trigger ischemic tolerance in mouse retina. Exp. Eye Res., 2006, 82, 153-163.
204. Crack, P. J.; Taylor, J. M. Reactive oxygen species and the modulation of stroke. Free Radic. Biol. Med., 2005, 38, 1433-1444.
205. Bianchi, M. E.; Manfredi, A. A. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunol. Rev., 2007, 220, 35-46.
206. Kono, H.; Rock, K. L. How dying cells alert the immune system to danger. Nat. Rev. Immunol., 2008, 8, 279-289.
207. Rock, F. L.; Hardiman, G.; Timans, J. C.; Kastelein, R. A.; Bazan, J. F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. U. S. A., 1998, 95, 588-593.
208. Fadok, V. A.; Bratton, D. L.; Konowal, A.; Freed, P. W.; Westcott, J. Y.; Henson, P. M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest., 1998, 101, 890-898.
209. Fadok, V. A.; McDonald, P. P.; Bratton, D. L.; Henson, P. M. Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. Biochem. Soc. Trans., 1998, 26, 653-656.
210. Voll, R. E.; Herrmann, M.; Roth, E. A.; Stach, C.; Kalden, J. R.; Girkontaite, I. Immunosuppressive effects of apoptotic cells. Nature, 1997, 390, 350-351.
211. Cherra, S. J.; Chu, C. T. Autophagy in neuroprotection and neurodegeneration: A question of balance. Future Neurol., 2008, 3, 309-323.
212. Wang, A. L.; Lukas, T. J.; Yuan, M.; Du, N.; Tso, M. O.; Neufeld, A. H. Autophagy, exosomes and drusen formation in age-related macular degeneration. Autophagy, 2009, 5, 563-564.
213. Donato, A. J.; Black, A. D.; Jablonski, K. L.; Gano, L. B.; Seals, D. R. Aging is associated with greater nuclear NF kappa B, reduced I kappa B alpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell., 2008, 7, 805-812.
214. Suematsu, M.; Suzuki, H.; Delano, F. A.; Schmid-Schonbein, G. W. The inflammatory aspect of the microcirculation in hypertension: oxidative stress, leukocytes/endothelial interaction, apoptosis. Microcirculation, 2002, 9, 259-276.
215. Chan-Ling, T.; Hughes, S.; Baxter, L.; Rosinova, E.; McGregor, I.; Morcos, Y.; van Nieuwenhuyzen, P.; Hu, P. Inflammation and breakdown of the blood-retinal barrier during "physiological aging" in the rat retina: a model for CNS aging. Microcirculation, 2007, 14, 63-76.
216. Ryan, G. B.; Majno, G. Acute inflammation. A review. Am. J. Pathol., 1977, 86, 183-276.
217. Ma, T.Y.; Iwamoto, G.K.; Hoa, N.T.; Akotia, V.; Pedram, A.; Boivin, M.A.; Said, H.M. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol., 2004, 286, G367-76.
218. Stamatovic, S. M.; Keep, R. F.; Kunkel, S. L.; Andjelkovic, A. V. Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J. Cell. Sci., 2003, 116, 4615-4628.
219. Edens, H. A.; Parkos, C. A. Modulation of epithelial and endothelial paracellular permeability by leukocytes. Adv. Drug Deliv. Rev., 2000, 41, 315-328.
220. Mrak, R. E.; Griffin, W. S. Glia and their cytokines in progression of neurodegeneration. Neurobiol. Aging, 2005, 26, 349-354.
221. Xu, H.; Chen, M.; Manivannan, A.; Lois, N.; Forrester, J. V. Agedependent accumulation of lipofuscin in perivascular and subretinal microglia in experimental mice. Aging Cell., 2008, 7, 58-68.
222. McMenamin, P. G.; Loeffler, K. U. Cells resembling intraventricular macrophages are present in the subretinal space of human foetal eyes. Anat. Rec., 1990, 227, 245-253.
223. Ng, T. F.; Streilein, J. W. Light-induced migration of retinal microglia into the subretinal space. Invest. Ophthalmol. Vis. Sci., 2001, 42, 3301-3310.
224. Hughes, E.H.; Schlichtenbrede, F.C.; Murphy, C.C.; Sarra, G.M.; Luthert, P.J.; Ali, R.R.; Dick, A.D. Generation of activated sialoadhesin-positive microglia during retinal degeneration. Invest. Ophthalmol. Vis. Sci., 2003, 44, 2229-2234.
225. Combadière, C.; Feumi, C.; Raoul, W.; Keller, N.; Rodéro, M.; Pézard, A.; Lavalette, S.; Houssier, M.; Jonet, L.; Picard, E.; Debré, P.; Sirinyan, M.; Deterre, P.; Ferroukhi, T.; Cohen, S.Y.; Chauvaud, D.; Jeanny, J.C.; Chemtob, S.; Behar-Cohen, F.; Sennlaub, F. CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J. Clin. Invest., 2007, 117, 2920-2928.
226. Lopes, K. O.; Sparks, D. L.; Streit, W. J. Microglial dystrophy in the aged and Alzheimer's disease brain is associated with ferritin immunoreactivity. Glia, 2008, 56, 1048-1060.
227. Terao, A.; Apte-Deshpande, A.; Dousman, L.; Morairty, S.; Eynon, B.P.; Kilduff, T.S.; Freund, Y.R. Immune response gene expression increases in the aging murine hippocampus. J. Neuroimmunol., 2002, 132, 99-112.
228. Sheng, J. G.; Mrak, R. E.; Griffin, W. S. Enlarged and phagocytic, but not primed, interleukin-1 alpha-immunoreactive microglia increase with age in normal human brain. Acta Neuropathol., 1998, 95, 229-234.
229. Sheng, J. G.; Griffin, W. S.; Royston, M. C.; Mrak, R. E. Distribution of interleukin-1-immunoreactive microglia in cerebral cortical layers: implications for neuritic plaque formation in Alzheimer's disease. Neuropathol. Appl. Neurobiol., 1998, 24, 278-283.
230. Felzien, L. K.; McDonald, J. T.; Gleason, S. M.; Berman, N. E.; Klein, R. M. Increased chemokine gene expression during aging in the murine brain. Brain Res., 2001, 890, 137-146.
231. Xu, H.; Chen, M.; Forrester, J. V. Para-inflammation in the aging retina. Prog. Retin. Eye Res., 2009, 28, 348-368.
232. Lavi, E.; Strizki, J.M.; Ulrich, A.M.; Zhang, W.; Fu, L.; Wang, Q.; O'Connor, M.; Hoxie, J.A.; González-Scarano, F. CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am. J. Pathol., 1997, 151, 1035-1042.
233. He, J.; Chen, Y.; Farzan, M.; Choe, H.; Ohagen, A.; Gartner, S.; Busciglio, J.; Yang, X.; Hofmann, W.; Newman, W.; Mackay, C.R.; Sodroski, J.; Gabuzda, D. CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature, 1997, 385, 645-649.
234. Mevorach, D. Opsonization of apoptotic cells. Implications for uptake and autoimmunity. Ann. N. Y. Acad. Sci., 2000, 926, 226-235.
235. Mevorach, D.; Mascarenhas, J. O.; Gershov, D.; Elkon, K. B. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med., 1998, 188, 2313-2320.
236. Takizawa, F.; Tsuji, S.; Nagasawa, S. Enhancement of macrophage phagocytosis upon iC3b deposition on apoptotic cells. FEBS Lett., 1996, 397, 269-272.
237. Chen, H.; Liu, B.; Lukas, T. J.; Neufeld, A. H. The aged retinal pigment epithelium/choroid: a potential substratum for the pathogenesis of age-related macular degeneration. PLoS One, 2008, 3, e2339.
238. Chen, M.; Muckersie, E.; Robertson, M.; Forrester, J. V.; Xu, H. Up-regulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina. Exp. Eye Res., 2008, 87, 543-550.
239. Higgins, G. T.; Wang, J. H.; Dockery, P.; Cleary, P. E.; Redmond, H. P. Induction of angiogenic cytokine expression in cultured RPE by ingestion of oxidized photoreceptor outer segments. Invest. Ophthalmol. Vis. Sci., 2003, 44, 1775-1782.
240. Herrero, C.; Sebastián, C.; Marqués, L.; Comalada, M.; Xaus, J.; Valledor, A.F.; Lloberas, J.; Celada, A. Immunosenescence of macrophages: reduced MHC class II gene expression. Exp. Gerontol., 2002, 37, 389-394.
241. Renshaw, M.; Rockwell, J.; Engleman, C.; Gewirtz, A.; Katz, J.; Sambhara, S. Cutting edge: impaired Toll-like receptor expression and function in aging. J. Immunol., 2002, 169, 4697-4701.
242. De La Fuente, M. Changes in the macrophage function with aging. Comp. Biochem. Physiol. A. Comp. Physiol., 1985, 81, 935-938.
243. De la Fuente, M.; Medina, S.; Del Rio, M.; Ferrandez, M. D.; Hernanz, A. Effect of aging on the modulation of macrophage functions by neuropeptides. Life Sci., 2000, 67, 2125-2135.
244. Khare, V.; Sodhi, A.; Singh, S. M. Effect of aging on the tumoricidal functions of murine peritoneal macrophages. Nat. Immun., 1996, 15, 285-294.
245. Helmy, K.Y.; Katschke, K.J. Jr.; Gorgani, N.N.; Kljavin, N.M.; Elliott, J.M.; Diehl, L.; Scales, S. J; Ghilardi, N.; van Lookeren Campagne, M. CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell, 2006, 124, 915-927.
246. Gorgani, N.N.; He, J.Q.; Katschke, K.J. Jr.; Helmy, K.Y.; Xi, H.; Steffek, M.; Hass, P.E.; van Lookeren Campagne, M. Complement receptor of the Ig superfamily enhances complement-mediated phagocytosis in a subpopulation of tissue resident macrophages. J. Immunol., 2008, 181, 7902-7908.
247. Kelly, J.; Ali Khan, A.; Yin, J.; Ferguson, T. A.; Apte, R. S. Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J. Clin. Invest., 2007, 117, 3421-3426.
248. Hageman, G. S.; Luthert, P. J.; Victor Chong, N. H.; Johnson, L. V.; Anderson, D. H.; Mullins, R. F. An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog. Retin. Eye Res., 2001, 20, 705-732.
249. Nowak, J. Z. Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol. Rep., 2006, 58, 353-363.
250. Donoso, L. A.; Kim, D.; Frost, A.; Callahan, A.; Hageman, G. The role of inflammation in the pathogenesis of age-related macular degeneration. Surv. Ophthalmol., 2006, 51, 137-152.
251. Kijlstra, A.; La Heij, E.; Hendrikse, F. Immunological factors in the pathogenesis and treatment of age-related macular degeneration. Ocul. Immunol. Inflamm., 2005, 13, 3-11.
252. Bergmann, M.; Schutt, F.; Holz, F. G.; Kopitz, J. Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J., 2004, 18, 562-564.
253. Sivaprasad, S.; Bailey, T. A.; Chong, V. N. Bruch's membrane and the vascular intima: is there a common basis for age-related changes and disease? Clin. Experiment. Ophthalmol., 2005, 33, 518-523.
254. Kaarniranta, K.; Salminen, A. Age-related macular degeneration: activation of innate immunity system via pattern recognition receptors. J. Mol. Med., 2009, 87, 117-123.
255. Fukuoka, Y.; Strainic, M.; Medof, M. E. Differential cytokine expression of human retinal pigment epithelial cells in response to stimulation by C5a. Clin. Exp. Immunol., 2003, 131, 248-253.
256. Johnson, P. T.; Betts, K. E.; Radeke, M. J.; Hageman, G. S.; Anderson, D. H.; Johnson, L. V. Individuals homozygous for the age-related macular degeneration risk-conferring variant of complement factor H have elevated levels of CRP in the choroid. Proc. Natl. Acad. Sci. U. S. A., 2006, 103, 17456-17461.
257. Mullins, R. F.; Russell, S. R.; Anderson, D. H.; Hageman, G. S. Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease. FASEB J., 2000, 14, 835-846.
258. Johnson, L. V.; Leitner, W. P.; Rivest, A. J.; Staples, M. K.; Radeke, M. J.; Anderson, D. H. The Alzheimer's A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 11830-11835.
259. Dentchev, T.; Milam, A. H.; Lee, V. M.; Trojanowski, J. Q.; Dunaief, J. L. Amyloid-beta is found in drusen from some agerelated macular degeneration retinas, but not in drusen from normal retinas. Mol. Vis., 2003, 9, 184-190.
260. Petrilli, V.; Dostert, C.; Muruve, D. A.; Tschopp, J. The inflammasome: a danger sensing complex triggering innate immunity. Curr. Opin. Immunol., 2007, 19, 615-622.
261. Halle, A.; Hornung, V.; Petzold, G.C.; Stewart, C.R.; Monks, B.G.; Reinheckel, T.; Fitzgerald, K.A.; Latz, E.; Moore, K.J.; Golenbock, D.T. The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat. Immunol., 2008, 9, 857-865.
262. Sparrow, J. R.; Boulton, M. RPE lipofuscin and its role in retinal pathobiology. Exp. Eye Res., 2005, 80, 595-606.
263. Jozsi, M.; Zipfel, P. F. Factor H family proteins and human diseases. Trends Immunol., 2008, 29, 380-387.
264. Hageman, G.S.; Anderson, D.H.; Johnson, L.V.; Hancox, L.S.; Taiber, A.J.; Hardisty, L.I.; Hageman, J.L.; Stockman, H.A.; Borchardt, J.D.; Gehrs, K.M.; Smith, R.J.; Silvestri, G.; Russell, S.R.; Klaver, C.C.; Barbazetto, I.; Chang, S.; Yannuzzi, L.A.; Barile, G.R.; Merriam, J.C.; Smith, R.T.; Olsh, A.K.; Bergeron, J.; Zernant, J.; Merriam, J.E.; Gold, B.; Dean, M.; Allikmets, R. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A., 2005, 102, 7227-7232.
265. Wu, Z.; Lauer, T. W.; Sick, A.; Hackett, S. F.; Campochiaro, P. A. Oxidative stress modulates complement factor H expression in retinal pigmented epithelial cells by acetylation of FOXO3. J. Biol. Chem., 2007, 282, 22414-22425.
266. Chen, M.; Forrester, J. V.; Xu, H. Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. Exp. Eye Res., 2007, 84, 635-645.
267. Schaumberg, D. A.; Christen, W. G.; Kozlowski, P.; Miller, D. T.; Ridker, P. M.; Zee, R. Y. A prospective assessment of the Y402H variant in complement factor H, genetic variants in C-reactive protein, and risk of age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 2006, 47, 2336-2340.
268. Miyake, K. Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors. Semin. Immunol., 2007, 19, 3-10.
269. Yu, M.; Wang, H.; Ding, A.; Golenbock, D.T.; Latz, E.; Czura, C.J.; Fenton, M.J.; Tracey, K.J.; Yang, H. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock, 2006, 26, 174-179.
270. Sugano, E.; Tomita, H.; Ishiguro, S.; Isago, H.; Tamai, M. Nitric oxide-induced accumulation of lipofuscin-like materials is caused by inhibition of cathepsin S. Curr. Eye Res., 2006, 31, 607-616.
271. Yang, D.; Elner, S. G.; Bian, Z. M.; Till, G. O.; Petty, H. R.; Elner, V. M. Pro-inflammatory cytokines increase reactive oxygen species through mitochondria and NADPH oxidase in cultured RPE cells. Exp. Eye Res., 2007, 85, 462-472.
272. Ebihara, N.; Chen, L.; Tokura, T.; Ushio, H.; Iwatsu, M.; Murakami, A. Distinct functions between toll-like receptors 3 and 9 in retinal pigment epithelial cells. Ophthalmic Res., 2007, 39, 155-163.
273. Elner, S.G.; Petty, H.R.; Elner, V.M.; Yoshida, A.; Bian, Z.M.; Yang, D.; Kindzelskii, A.L. TLR4 mediates human retinal pigment epithelial endotoxin binding and cytokine expression. Invest. Ophthalmol. Vis. Sci., 2005, 46, 4627-4633.
274. Paimela, T.; Ryhänen, T.; Mannermaa, E.; Ojala, J.; Kalesnykas, G.; Salminen, A.; Kaarniranta, K. The effect of 17beta-estradiol on IL-6 secretion and NF-kappaB DNA-binding activity in human retinal pigment epithelial cells. Immunol. Lett., 2007, 110, 139-144.
275. Blander, J. M. Signalling and phagocytosis in the orchestration of host defence. Cell. Microbiol., 2007, 9, 290-299.
276. Hollyfield, J. G.; Rayborn, M. E.; Tammi, R. Hyaluronan localization in tissues of the mouse posterior eye wall: absence in the interphotoreceptor matrix. Exp. Eye Res., 1997, 65, 603-608.
277. Howes, K.A.; Liu, Y.; Dunaief, J.L.; Milam, A.; Frederick, J.M.; Marks, A.; Baehr, W. Receptor for advanced glycation end products and age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 2004, 45, 3713-3720.
278. Yamada, Y.; Ishibashi, K.; Ishibashi, K.; Bhutto, I.A.; Tian, J.; Lutty, G.A.; Handa, J.T. The expression of advanced glycation endproduct receptors in rpe cells associated with basal deposits in human maculas. Exp. Eye Res., 2006, 82, 840-848.
279. Ma, W.; Lee, S.E.; Guo, J.; Qu, W.; Hudson, B.I.; Schmidt, A.M.; Barile, G.R. RAGE ligand upregulation of VEGF secretion in ARPE-19 cells. Invest. Ophthalmol. Vis. Sci., 2007, 48, 1355-1361.
280. Hazen, S. L. Oxidized phospholipids as endogenous pattern recognition ligands in innate immunity. J. Biol. Chem., 2008, 283, 15527-15531.
281. Duncan, K. G.; Bailey, K. R.; Kane, J. P.; Schwartz, D. M. Human retinal pigment epithelial cells express scavenger receptors BI and BII. Biochem. Biophys. Res. Commun., 2002, 292, 1017-1022.
282. Primo, L.; Ferrandi, C.; Roca, C.; Marchiò, S.; di Blasio, L.; Alessio, M.; Bussolino, F. Identification of CD36 molecular features required for its in vitro angiostatic activity. FASEB J., 2005, 19, 1713-1715.
283. Houssier, M.; Raoul, W.; Lavalette, S.; Keller, N.; Guillonneau, X.; Baragatti, B.; Jonet, L.; Jeanny, J.C.; Behar-Cohen, F.; Coceani, F.; Scherman, D.; Lachapelle, P.; Ong, H.; Chemtob, S.; Sennlaub, F. CD36 deficiency leads to choroidal involution via COX2 downregulation in rodents. PLoS Med., 2008, 5, e39.
284. Gupta, N.; Brown, K. E.; Milam, A. H. Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp. Eye Res., 2003, 76, 463-471.
285. Houssier, M.; Raoul, W.; Lavalette, S.; Keller, N.; Guillonneau, X.; Baragatti, B.; Jonet, L.; Jeanny, J.C.; Behar-Cohen, F.; Coceani, F.; Scherman, D.; Lachapelle, P.; Ong, H.; Chemtob, S.; Sennlaub, F. Murine ccl2/cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration. Invest. Ophthalmol. Vis. Sci., 2007, 48, 3827-3836.
286. Ma, W.; Zhao, L.; Fontainhas, A. M.; Fariss, R. N.; Wong, W. T. Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLoS One, 2009, 4, e7945.
287. Osusky, R.; Malik, P.; Aurora, Y.; Ryan, S. J. Monocytemacrophage differentiation induced by coculture of retinal pigment epithelium cells with monocytes. Ophthalmic Res., 1997, 29, 124-129.
288. Crabb, J.W.; Miyagi, M.; Gu, X.; Shadrach, K.; West, K.A.; Sakaguchi, H.; Kamei, M.; Hasan, A.; Yan, L.; Rayborn, M.E.; Salomon, R.G.; Hollyfield, J.G. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc. Natl. Acad. Sci. U. S. A., 2002, 99, 14682-14687.
289. Umeda, S.; Suzuki, M.T.; Okamoto, H.; Ono, F.; Mizota, A.; Terao, K.; Yoshikawa, Y.; Tanaka, Y.; Iwata, T. Molecular composition of drusen and possible involvement of anti-retinal autoimmunity in two different forms of macular degeneration in cynomolgus monkey (Macaca fascicularis). FASEB J., 2005, 19, 1683-1685.
290. Ishida, O.; Oku, H.; Ikeda, T.; Nishimura, M.; Kawagoe, K.; Nakamura, K. Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration? Br. J. Ophthalmol., 2003, 87, 523-524.
291. Kalayoglu, M. V.; Galvan, C.; Mahdi, O. S.; Byrne, G. I.; Mansour, S. Serological association between Chlamydia pneumoniae infection and age-related macular degeneration. Arch. Ophthalmol., 2003, 121, 478-482.
292. Jabs, D. A.; Nussenblatt, R. B.; Rosenbaum, J. T.; Standardization of Uveitis Nomenclature (SUN) Working Group Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am. J. Ophthalmol., 2005, 140, 509-516.
293. Srivastava, A.; Rajappa, M.; Kaur, J. Uveitis: Mechanisms and recent advances in therapy. Clin. Chim. Acta, 2010, 411, 1165-1171.
294. Wakefield, D.; Chang, J. H. Epidemiology of uveitis. Int. Ophthalmol. Clin., 2005, 45, 1-13.
295. Chang, J. H.; Wakefield, D. Uveitis: a global perspective. Ocul. Immunol. Inflamm., 2002, 10, 263-279.
296. Chang, J. H.; McCluskey, P. J.; Wakefield, D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br. J. Ophthalmol., 2006, 90, 103-108.
297. Deschenes, J.; Char, D. H.; Kaleta, S. Activated T lymphocytes in uveitis. Br. J. Ophthalmol., 1988, 72, 83-87.
298. Calder, V.L.; Shaer, B.; Muhaya, M.; Mclauchlan, M.; Pearson, R.V.; Jolly, G.; Towler, H.M.; Lightman, S. Increased CD4+ expression and decreased IL-10 in the anterior chamber in idiopathic uveitis. Invest. Ophthalmol. Vis. Sci., 1999, 40, 2019-2024.
299. Bodaghi, B.; Rao, N. Relevance of animal models to human uveitis. Ophthalmic Res., 2008, 40, 200-202.
300. Rosenbaum, J. T.; Samples, J. R.; Hefeneider, S. H.; Howes, E. L., Jr Ocular inflammatory effects of intravitreal interleukin 1. Arch. Ophthalmol., 1987, 105, 1117-1120.
301. Smith, J. R.; Hart, P. H.; Williams, K. A. Basic pathogenic mechanisms operating in experimental models of acute anterior uveitis. Immunol. Cell Biol., 1998, 76, 497-512.
302. Szily, A. Experimental endogenous transmission of infection from bulbus to bulbus. Klin. Monatsbl. Augenheilkd., 1924, 72, 593.
303. Rao, N.A.; Kimoto, T.; Zamir, E.; Giri, R.; Wang, R.; Ito, S.; Pararajasegaram, G.; Read, R.; Wu, G.S. Pathogenic role of retinal microglia in experimental uveoretinitis. Invest. Ophthalmol. Vis. Sci., 2003, 44, 22-31.
304. Dua, H. S.; Abrams, M.; Barrett, J. A.; Gregerson, D. S.; Forrester, J. V.; Donoso, L. A. Epitopes and idiotypes in experimental autoimmune uveitis: a review. Curr. Eye Res., 1992, 11 (Suppl), 59-65.
305. Fauser, S.; Nguyen, T. D.; Bekure, K.; Schluesener, H. J.; Meyermann, R. Differential activation of microglial cells in local and remote areas of IRBP1169-1191-induced rat uveitis. Acta Neuropathol., 2001, 101, 565-571.
306. Schluesener, H. J.; Seid, K.; Zhao, Y.; Meyermann, R. Localization of endothelial-monocyte-activating polypeptide II (EMAP II), a novel proinflammatory cytokine, to lesions of experimental autoimmune encephalomyelitis, neuritis and uveitis: expression by monocytes and activated microglial cells. Glia, 1997, 20, 365-372.
307. Schluesener, H. J.; Seid, K.; Kretzschmar, J.; Meyermann, R. Allograft-inflammatory factor-1 in rat experimental autoimmune encephalomyelitis, neuritis, and uveitis: expression by activated macrophages and microglial cells. Glia, 1998, 24, 244-251.
308. Lu, Q.; Lemke, G. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science, 2001, 293, 306-311.
309. Dick, A. D.; Broderick, C.; Forrester, J. V.; Wright, G. J. Distribution of OX2 antigen and OX2 receptor within retina. Invest. Ophthalmol. Vis. Sci., 2001, 42, 170-176.
310. Wright, G. J.; Puklavec, M. J.; Willis, A. C.; Hoek, R. M.; Sedgwick, J. D.; Brown, M. H.; Barclay, A. N. Lymphoid/neuronal cell surface OX2 glycoprotein recognizes a novel receptor on macrophages implicated in the control of their function. Immunity, 2000, 13, 233-242.
311. Preston, S.; Wright, G. J.; Starr, K.; Barclay, A. N.; Brown, M. H. The leukocyte/neuron cell surface antigen OX2 binds to a ligand on macrophages. Eur. J. Immunol., 1997, 27, 1911-1918.
312. Broderick, C.; Hoek, R. M.; Forrester, J. V.; Liversidge, J.; Sedgwick, J. D.; Dick, A. D. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am. J. Pathol., 2002, 161, 1669-1677.
313. Nussenblatt, R. B. Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Invest. Ophthalmol. Vis. Sci., 1991, 32, 3131-3141.
314. Baccala, R.; Kono, D. H.; Theofilopoulos, A. N. Interferons as pathogenic effectors in autoimmunity. Immunol. Rev., 2005, 204, 9-26.
315. Gordon, S. Alternative activation of macrophages. Nat. Rev. Immunol., 2003, 3, 23-35.
316. Hamel, C. P.; Detrick, B.; Hooks, J. J. Evaluation of Ia expression in rat ocular tissues following inoculation with interferon-gamma. Exp. Eye Res., 1990, 50, 173-182.
317. Feldmann, M.; Londei, M.; Buchan, G. Interferons and autoimmunity. Interferon, 1987, 9, 75-90.
318. Yoshida, A.; Koide, Y.; Uchijima, M.; Yoshida, T. O. IFN-gamma induces IL-12 mRNA expression by a murine macrophage cell line, J774. Biochem. Biophys. Res. Commun., 1994, 198, 857-861.
319. Wu, Y.; Lin, Y.; Hou, W.; Wang, Y.; Sun, B. IFN-gamma upregulation of IL-12 beta 2 receptor is associated with experimental autoimmune uveitis susceptible B10. A mice, but not in EAU resistant BALB/c mice. J. Neuroimmunol., 2003, 137, 154-163.
320. Tarrant, T.K.; Silver, P.B.; Wahlsten, J.L.; Rizzo, L.V.; Chan, C.C.; Wiggert, B.; Caspi, R.R. Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. J. Exp. Med., 1999, 189, 219-230.
321. Fan, H.; Walters, C. S.; Dunston, G. M.; Tackey, R. IL-12 plays a significant role in the apoptosis of human T cells in the absence of antigenic stimulation. Cytokine, 2002, 19, 126-137.
322. Dick, A. D.; Forrester, J. V.; Liversidge, J.; Cope, A. P. The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU). Prog. Retin. Eye Res., 2004, 23, 617-637.
323. Nakamura, S.; Yamakawa, T.; Sugita, M.; Kijima, M.; Ishioka, M.; Tanaka, S.; Ohno, S. The role of tumor necrosis factor-alpha in the induction of experimental autoimmune uveoretinitis in mice. Invest. Ophthalmol. Vis. Sci., 1994, 35, 3884-3889.
324. Dick, A. D.; Duncan, L.; Hale, G.; Waldmann, H.; Isaacs, J. Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis. J. Autoimmun., 1998, 11, 255-264.
325. Wang, C. Y.; Mayo, M. W.; Korneluk, R. G.; Goeddel, D. V.; Baldwin, A. S., Jr. NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science, 1998, 281, 1680-1683.
326. Ferrick, M.R.; Thurau, S.R.; Oppenheim, M.H.; Herbort, C.P.; Ni, M.; Zachariae, C.O.; Matsushima, K.; Chan, C.C. Ocular inflammation stimulated by intravitreal interleukin-8 and interleukin-1. Invest. Ophthalmol. Vis. Sci., 1991, 32, 1534-1539.
327. Bamforth, S. D.; Lightman, S. L.; Greenwood, J. Ultrastructural analysis of interleukin-1 beta-induced leukocyte recruitment to the rat retina. Invest. Ophthalmol. Vis. Sci., 1997, 38, 25-35.
328. Ohta, K.; Wiggert, B.; Yamagami, S.; Taylor, A. W.; Streilein, J. W. Analysis of immunomodulatory activities of aqueous humor from eyes of mice with experimental autoimmune uveitis. J. Immunol., 2000, 164, 1185-1192.
329. Cousins, S. W.; McCabe, M. M.; Danielpour, D.; Streilein, J. W. Identification of transforming growth factor-beta as an immunosuppressive factor in aqueous humor. Invest. Ophthalmol. Vis. Sci., 1991, 32, 2201-2211.
330. Yotsukura, J.; Huang, H.; Singh, A. K.; Shichi, H. Regulatory cells generated by testicular tolerization to retinal S-antigen: possible involvement of IL-4, IL-10, and TGF-beta in the suppression of experimental autoimmune uveoretinitis. Cell. Immunol., 1997, 182, 89-98.
331. Fiorentino, D.F.; Zlotnik, A.; Vieira, P.; Mosmann, T.R.; Howard, M.; Moore, K.W.; O'Garra, A. IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells. J. Immunol., 1991, 146, 3444-3451.
332. Sun, B.; Sun, S. H.; Chan, C. C.; Caspi, R. R. Evaluation of in vivo cytokine expression in EAU-susceptible and resistant rats: a role for IL-10 in resistance? Exp. Eye Res., 2000, 70, 493-502.
333. Samples, J. R.; Boney, R. S.; Rosenbaum, J. T. Ocular inflammatory effects of intravitreally injected interleukin-2. Curr. Eye Res., 1993, 12, 649-654.
334. Rizzo, L. V.; Miller-Rivero, N. E.; Chan, C. C.; Wiggert, B.; Nussenblatt, R. B.; Caspi, R. R. Interleukin-2 treatment potentiates induction of oral tolerance in a murine model of autoimmunity. J. Clin. Invest., 1994, 94, 1668-1672.
335. Yang, C. H.; Fang, I. M.; Lin, C. P.; Yang, C. M.; Chen, M. S. Effects of the NF-kappaB inhibitor pyrrolidine dithiocarbamate on experimentally induced autoimmune anterior uveitis. Invest. Ophthalmol. Vis. Sci., 2005, 46, 1339-1347.
336. Silverman, M.D.; Zamora, D.O.; Pan, Y.; Texeira, P.V.; Baek, S.H.; Planck, S.R.; Rosenbaum, J.T. Constitutive and inflammatory mediator-regulated fractalkine expression in human ocular tissues and cultured cells. Invest. Ophthalmol. Vis. Sci., 2003, 44, 1608-1615.
337. Fang, I. M.; Lin, C. P.; Yang, C. M.; Chen, M. S.; Yang, C. H. Expression of CX3C chemokine, fractalkine, and its receptor CX3CR1 in experimental autoimmune anterior uveitis. Mol. Vis., 2005, 11, 443-451.
338. Quigley, H. A. Number of people with glaucoma worldwide. Br. J. Ophthalmol., 1996, 80, 389-393.
339. Nguyen, S. M.; Alexejun, C. N.; Levin, L. A. Amplification of a reactive oxygen species signal in axotomized retinal ganglion cells. Antioxid. Redox Signal., 2003, 5, 629-634.
340. Tezel, G.; Wax, M. B. Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J. Neurosci., 2000, 20, 8693-8700.
341. Anderson, D. R.; Hendrickson, A. Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest. Ophthalmol., 1974, 13, 771-783.
342. Minckler, D. S.; Tso, M. O.; Zimmerman, L. E. A light microscopic, autoradiographic study of axoplasmic transport in the optic nerve head during ocular hypotony, increased intraocular pressure, and papilledema. Am. J. Ophthalmol., 1976, 82, 741-757.
343. Quigley, H. A.; Addicks, E. M. Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest. Ophthalmol. Vis. Sci., 1980, 19, 137-152.
344. Pease, M. E.; McKinnon, S. J.; Quigley, H. A.; Kerrigan-Baumrind, L. A.; Zack, D. J. Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest. Ophthalmol. Vis. Sci., 2000, 41, 764-774.
345. Tezel, G. Oxidative stress in glaucomatous neurodegeneration: mechanisms and consequences. Prog. Retin. Eye Res., 2006, 25, 490-513.
346. Wax, M. B.; Barrett, D. A.; Pestronk, A. Increased incidence of paraproteinemia and autoantibodies in patients with normalpressure glaucoma. Am. J. Ophthalmol., 1994, 117, 561-568.
347. Wax, M. B.; Tezel, G.; Edward, P. D. Clinical and ocular histopathological findings in a patient with normal-pressure glaucoma. Arch. Ophthalmol., 1998, 116, 993-1001.
348. Tezel, G.; Edward, D. P.; Wax, M. B. Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch. Ophthalmol., 1999, 117, 917-924.
349. Romano, C.; Barrett, D. A.; Li, Z.; Pestronk, A.; Wax, M. B. Antirhodopsin antibodies in sera from patients with normal-pressure glaucoma. Invest. Ophthalmol. Vis. Sci., 1995, 36, 1968-1975.
350. Wax, M.B.; Tezel, G.; Saito, I.; Gupta, R.S.; Harley, J.B.; Li, Z.; Romano, C. Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am. J. Ophthalmol., 1998, 125, 145-157.
351. Tezel, G.; Seigel, G. M.; Wax, M. B. Autoantibodies to small heat shock proteins in glaucoma. Invest. Ophthalmol. Vis. Sci., 1998, 39, 2277-2287.
352. Wax, M. B.; Tezel, G.; Kawase, K.; Kitazawa, Y. Serum autoantibodies to heat shock proteins in glaucoma patients from Japan and the United States. Ophthalmology, 2001, 108, 296-302.
353. Yang, J.; Tezel, G.; Patil, R. V.; Romano, C.; Wax, M. B. Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest. Ophthalmol. Vis. Sci., 2001, 42, 1273-1276.
354. Tezel, G.; Wax, M. B. The mechanisms of hsp27 antibodymediated apoptosis in retinal neuronal cells. J. Neurosci., 2000, 20, 3552-3562.
355. Wax, M. B.; Tezel, G. Immunoregulation of retinal ganglion cell fate in glaucoma. Exp. Eye Res., 2009, 88, 825-830.
356. Maruyama, I.; Maeda, T.; Okisaka, S.; Mizukawa, A.; Nakazawa, M.; Ohguro, H. Autoantibody against neuron-specific enolase found in glaucoma patients causes retinal dysfunction in vivo. Jpn. J. Ophthalmol., 2002, 46, 1-12.
357. Kremmer, S.; Kreuzfelder, E.; Klein, R.; Bontke, N.; Henneberg-Quester, K.B.; Steuhl, K.P.; Grosse-Wilde, H. Antiphosphatidylserine antibodies are elevated in normal tension glaucoma. Clin. Exp. Immunol., 2001, 125, 211-215.
358. Joachim, S. C.; Pfeiffer, N.; Grus, F. H. Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens. Graefes Arch. Clin. Exp. Ophthalmol., 2005, 243, 817-823.
359. Stasi, K.; Nagel, D.; Yang, X.; Wang, R. F; Ren, L.; Podos, S.M.; Mittag, T.; Danias, J. Complement component 1Q (C1Q) upregulation in retina of murine, primate, and human glaucomatous eyes. Invest. Ophthalmol. Vis. Sci., 2006, 47, 1024-1029.
360. Kuehn, M.H.; Kim, C.Y.; Ostojic, J.; Bellin, M.; Alward, W.L.; Stone, E.M.; Sakaguchi, D. S; Grozdanic, S.D.; Kwon, Y.H. Retinal synthesis and deposition of complement components induced by ocular hypertension. Exp. Eye Res., 2006, 83, 620-628.
361. Stevens, B.; Allen, N.J.; Vazquez, L.E.; Howell, G.R.; Christopherson, K.S.; Nouri, N.; Micheva, K.D.; Mehalow, A.K.; Huberman, A.D.; Stafford, B.; Sher, A.; Litke, A.M.; Lambris, J.D.; Smith, S.J.; John, S.W.; Barres, B.A. The classical complement cascade mediates CNS synapse elimination. Cell, 2007, 131, 1164-1178.
362. Yan, X.; Tezel, G.; Wax, M. B.; Edward, D. P. Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch. Ophthalmol., 2000, 118, 666-673.
363. Sun, D.; Hu, X.; Shah, R.; Zhang, L.; Coleclough, C. Production of tumor necrosis factor-alpha as a result of glia-T-cell interaction correlates with the pathogenic activity of myelin basic proteinreactive T cells in experimental autoimmune encephalomyelitis. J. Neurosci. Res., 1996, 45, 400-409.
364. Neufeld, A. H.; Hernandez, M. R.; Gonzalez, M. Nitric oxide synthase in the human glaucomatous optic nerve head. Arch. Ophthalmol., 1997, 115, 497-503.
365. Neufeld, A. H. Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch. Ophthalmol., 1999, 117, 1050-1056.
366. Tezel, G.; Hernandez, R.; Wax, M. B. Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. Arch. Ophthalmol., 2000, 118, 511-518.
367. Joachim, S. C.; Bruns, K.; Lackner, K. J.; Pfeiffer, N.; Grus, F. H. Antibodies to alpha B-crystallin, vimentin, and heat shock protein 70 in aqueous humor of patients with normal tension glaucoma and IgG antibody patterns against retinal antigen in aqueous humor. Curr. Eye Res., 2007, 32, 501-509.
368. Joachim, S. C.; Wuenschig, D.; Pfeiffer, N.; Grus, F. H. IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma. Mol. Vis., 2007, 13, 1573-1579.
369. Huang, W.; Fileta, J. B.; Filippopoulos, T.; Ray, A.; Dobberfuhl, A.; Grosskreutz, C. L. Hsp27 phosphorylation in experimental glaucoma. Invest. Ophthalmol. Vis. Sci., 2007, 48, 4129-4135.
370. Rutault, K.; Alderman, C.; Chain, B. M.; Katz, D. R. Reactive oxygen species activate human peripheral blood dendritic cells. Free Radic. Biol. Med., 1999, 26, 232-238.
371. Alderman, C. J.; Shah, S.; Foreman, J. C.; Chain, B. M.; Katz, D. R. The role of advanced oxidation protein products in regulation of dendritic cell function. Free Radic. Biol. Med., 2002, 32, 377-385.
372. Tezel, G.; Wax, M. B. The mechanisms of hsp27 antibodymediated apoptosis in retinal neuronal cells. J. Neurosci., 2000, 20, 3552-3562.
373. Tezel, G.; Yang, X.; Cai, J. Proteomic identification of oxidatively modified retinal proteins in a chronic pressure-induced rat model of glaucoma. Invest. Ophthalmol. Vis. Sci., 2005, 46, 3177-3187.
374. Tezel, G.; Luo, C.; Yang, X. Accelerated aging in glaucoma: immunohistochemical assessment of advanced glycation end products in the human retina and optic nerve head. Invest. Ophthalmol. Vis. Sci., 2007, 48, 1201-1211.
375. Carson, M. J. Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis. Glia, 2002, 40, 218-231.
376. Aloisi, F. The role of microglia and astrocytes in CNS immune surveillance and immunopathology. Adv. Exp. Med. Biol., 1999, 468, 123-133.
377. Maehlen, J.; Olsson, T.; Zachau, A.; Klareskog, L.; Kristensson, K. Local enhancement of major histocompatibility complex (MHC) class I and II expression and cell infiltration in experimental allergic encephalomyelitis around axotomized motor neurons. J. Neuroimmunol., 1989, 23, 125-132.
378. Molleston, M. C.; Thomas, M. L.; Hickey, W. F. Novel major histocompatibility complex expression by microglia and sitespecific experimental allergic encephalomyelitis lesions in the rat central nervous system after optic nerve transection. Adv. Neurol., 1993, 59, 337-348.
379. Tezel, G.; Wax, M. B. Glial modulation of retinal ganglion cell death in glaucoma. J. Glaucoma, 2003, 12, 63-68.
380. Levin, L. A. Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy. Surv. Ophthalmol., 1999, 43 (Suppl 1), S98-101.
381. Neufeld, A. H.; Sawada, A.; Becker, B. Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 9944-9948.
382. Tezel, G.; Li, L. Y.; Patil, R. V.; Wax, M. B. TNF-alpha and TNFalpha receptor-1 in the retina of normal and glaucomatous eyes. Invest. Ophthalmol. Vis. Sci., 2001, 42, 1787-1794.
383. Wang, X.; Sam-Wah Tay, S.; Ng, Y. K. Nitric oxide, microglial activities and neuronal cell death in the lateral geniculate nucleus of glaucomatous rats. Brain Res., 2000, 878, 136-147.
384. Tanihara, H.; Hangai, M.; Sawaguchi, S.; Abe, H.; Kageyama, M.; Nakazawa, F.; Shirasawa, E.; Honda, Y. Up-regulation of glial fibrillary acidic protein in the retina of primate eyes with experimental glaucoma. Arch. Ophthalmol., 1997, 115, 752-756.
385. Naka, M.; Kanamori, A.; Negi, A.; Nakamura, M. Reduced expression of aquaporin-9 in rat optic nerve head and retina following elevated intraocular pressure. Invest. Ophthalmol. Vis. Sci., 2010, 51, 4618-4626.
386. Naskar, R.; Wissing, M.; Thanos, S. Detection of early neuron degeneration and accompanying microglial responses in the retina of a rat model of glaucoma. Invest. Ophthalmol. Vis. Sci., 2002, 43, 2962-2968.
387. Mittag, T.W.; Danias, J.; Pohorenec, G.; Yuan, H.M.; Burakgazi, E.; Chalmers-Redman, R.; Podos, S.M.; Tatton, W.G. Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci., 2000, 41, 3451-3459.
388. Aiello, L. P.; Cahill, M. T.; Wong, J. S. Systemic considerations in the management of diabetic retinopathy. Am. J. Ophthalmol., 2001, 132, 760-776.
389. Adamis, A. P.; Berman, A. J. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin. Immunopathol., 2008, 30, 65-84.
390. Gardner, T. W.; Antonetti, D. A.; Barber, A. J.; LaNoue, K. F.; Levison, S. W. Diabetic retinopathy: more than meets the eye. Surv. Ophthalmol., 2002, 47 Suppl 2, S253-62.
391. Antonetti, D. A.; Lieth, E.; Barber, A. J.; Gardner, T. W. Molecular mechanisms of vascular permeability in diabetic retinopathy. Semin. Ophthalmol., 1999, 14, 240-248.
392. Barber, A. J.; Antonetti, D. A.; Gardner, T. W. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Invest. Ophthalmol. Vis. Sci., 2000, 41, 3561-3568.
393. Aiello, L.P.; Bursell, S.E.; Clermont, A.; Duh, E.; Ishii, H.; Takagi, C.; Mori, F.; Ciulla, T.A.; Ways, K.; Jirousek, M.; Smith, L.E.; King, G.L. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes, 1997, 46, 1473-1480.
394. Aiello, L. P.; Wong, J. S. Role of vascular endothelial growth factor in diabetic vascular complications. Kidney Int. Suppl., 2000, 77, S113-9.
395. Abbott, N. J.; Revest, P. A.; Romero, I. A. Astrocyte-endothelial interaction: physiology and pathology. Neuropathol. Appl. Neurobiol., 1992, 18, 424-433.
396. Gardner, T.W.; Lieth, E.; Khin, S.A.; Barber, A.J.; Bonsall, D.J.; Lesher, T.; Rice, K.; Brennan, W.A. Jr. Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. Invest. Ophthalmol. Vis. Sci., 1997, 38, 2423-2427.
397. Rungger-Brandle, E.; Dosso, A. A.; Leuenberger, P. M. Glial reactivity, an early feature of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci., 2000, 41, 1971-1980.
398. Hiscott, P. S.; Grierson, I.; Trombetta, C. J.; Rahi, A. H.; Marshall, J.; McLeod, D. Retinal and epiretinal glia--an immunohistochemical study. Br. J. Ophthalmol., 1984, 68, 698-707.
399. Lieth, E.; Barber, A.J.; Xu, B.; Dice, C.; Ratz, M.J.; Tanase, D.; Strother, J.M. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Penn State Retina Research Group. Diabetes, 1998, 47, 815-820.
400. Zeng, X. X.; Ng, Y. K.; Ling, E. A. Neuronal and microglial response in the retina of streptozotocin-induced diabetic rats. Vis. Neurosci., 2000, 17, 463-471.
401. Wolter, J.R. Diabetic retinopathy. Am. J. Ophthalmol., 1961, 51, 1123-1141.
402. Barber, A.J.; Nakamura, M.; Wolpert, E.B.; Reiter, C.E.; Seigel, G.M.; Antonetti, D.A.; Gardner, T.W. Insulin rescues retinal neurons from apoptosis by a phosphatidylinositol 3-kinase/Aktmediated mechanism that reduces the activation of caspase-3. J. Biol. Chem., 2001, 276, 32814-32821.
403. Nakamura, M.; Barber, A.J.; Antonetti, D.A.; LaNoue, K.F.; Robinson, K.A.; Buse, M.G.; Gardner, T.W. Excessive hexosamines block the neuroprotective effect of insulin and induce apoptosis in retinal neurons. J. Biol. Chem., 2001, 276, 43748-43755.
404. Lieth, E.; LaNoue, K. F.; Antonetti, D. A.; Ratz, M. Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. The Penn State Retina Research Group. Exp. Eye Res., 2000, 70, 723-730.
405. Barber, A. J.; Lieth, E.; Khin, S. A.; Antonetti, D. A.; Buchanan, A. G.; Gardner, T. W. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest., 1998, 102, 783-791.
406. Kern, T. S. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp. Diabetes Res., 2007, 2007, 95103.
407. Joussen, A. M.; Murata, T.; Tsujikawa, A.; Kirchhof, B.; Bursell, S. E.; Adamis, A. P. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am. J. Pathol., 2001, 158, 147-152.
408. Harris, A. G.; Skalak, T. C.; Hatchell, D. L. Leukocyte-capillary plugging and network resistance are increased in skeletal muscle of rats with streptozotocin-induced hyperglycemia. Int. J. Microcirc. Clin. Exp., 1994, 14, 159-166.
409. Kelly, L. W.; Barden, C. A.; Tiedeman, J. S.; Hatchell, D. L. Alterations in viscosity and filterability of whole blood and blood cell subpopulations in diabetic cats. Exp. Eye Res., 1993, 56, 341-347.
410. Miyamoto, K.; Khosrof, S.; Bursell, S.E.; Rohan, R.; Murata, T.; Clermont, A.C.; Aiello, L.P.; Ogura, Y.; Adamis, A.P. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc. Natl. Acad. Sci. U. S. A., 1999, 96, 10836-10841.
411. Joussen, A.M.; Poulaki, V.; Le, M.L.; Koizumi, K.; Esser, C.; Janicki, H.; Schraermeyer, U.; Kociok, N.; Fauser, S.; Kirchhof, B.; Kern, T.S.; Adamis, A.P. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J., 2004, 18, 1450-1452.
412. Joussen, A.M.; Poulaki, V.; Tsujikawa, A.; Qin, W.; Qaum, T.; Xu, Q.; Moromizato, Y.; Bursell, S.E.; Wiegand, S.J.; Rudge, J.; Ioffe, E.; Yancopoulos, G.D.; Adamis, A.P. Suppression of diabetic retinopathy with angiopoietin-1. Am. J. Pathol., 2002, 160, 1683-1693.
413. Boeri, D.; Maiello, M.; Lorenzi, M. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes, 2001, 50, 1432-1439.
414. Antonetti, D. A.; Barber, A. J.; Khin, S.; Lieth, E.; Tarbell, J. M.; Gardner, T. W. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. Diabetes, 1998, 47, 1953-1959.
415. Wilkinson-Berka, J. L. Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide. Curr. Pharm. Des., 2004, 10, 3331-3348.
416. Harhaj, N. S.; Felinski, E. A.; Wolpert, E. B.; Sundstrom, J. M.; Gardner, T. W.; Antonetti, D. A. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest. Ophthalmol. Vis. Sci., 2006, 47, 5106-5115.
417. Romeo, G.; Liu, W. H.; Asnaghi, V.; Kern, T. S.; Lorenzi, M. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. Diabetes, 2002, 51, 2241-2248.
418. Zheng, L.; Howell, S. J.; Hatala, D. A.; Huang, K.; Kern, T. S. Salicylate-based anti-inflammatory drugs inhibit the early lesion of diabetic retinopathy. Diabetes, 2007, 56, 337-345.
419. Zheng, L.; Szabo, C.; Kern, T. S. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes, 2004, 53, 2960-2967.
420. Kowluru, R. A.; Tang, J.; Kern, T. S. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes, 2001, 50, 1938-1942.
421. Zheng, L.; Du, Y.; Miller, C.; Gubitosi-Klug, R.A.; Ball, S.; Berkowitz, B.A.; Kern, T.S. Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes. Diabetologia, 2007, 50, 1987-1996.
422. Du, Y.; Smith, M. A.; Miller, C. M.; Kern, T. S. Diabetes-induced nitrative stress in the retina, and correction by aminoguanidine. J. Neurochem., 2002, 80, 771-779.
423. Ayalasomayajula, S. P.; Amrite, A. C.; Kompella, U. B. Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas. Eur. J. Pharmacol., 2004, 498, 275-278.
424. Ayalasomayajula, S. P.; Kompella, U. B. Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocininduced diabetic rat model. Eur. J. Pharmacol., 2003, 458, 283-289.
425. Joussen, A.M.; Poulaki, V.; Mitsiades, N.; Kirchhof, B.; Koizumi, K.; Döhmen, S.; Adamis, A.P. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J., 2002, 16, 438-440.
426. Du, Y.; Sarthy, V. P.; Kern, T. S. Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2004, 287, R735-41.
427. Lu, M.; Perez, V.L.; Ma, N.; Miyamoto, K.; Peng, H.B.; Liao, J.K.; Adamis, A.P. VEGF increases retinal vascular ICAM-1 expression in vivo. Invest. Ophthalmol. Vis. Sci., 1999, 40, 1808-1812.
428. Chen, W.; Jump, D. B.; Grant, M. B.; Esselman, W. J.; Busik, J. V. Dyslipidemia, but not hyperglycemia, induces inflammatory adhesion molecules in human retinal vascular endothelial cells. Invest. Ophthalmol. Vis. Sci., 2003, 44, 5016-5022.
429. Sone, H.; Kawakami, Y.; Okuda, Y.; Sekine, Y.; Honmura, S.; Matsuo, K.; Segawa, T.; Suzuki, H.; Yamashita, K. Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes. Diabetologia, 1997, 40, 726-730.
430. Gerhardinger, C.; Brown, L. F.; Roy, S.; Mizutani, M.; Zucker, C. L.; Lorenzi, M. Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. Am. J. Pathol., 1998, 152, 1453-1462.
431. Gawa, Y.; Shirao, Y.; Yamagishi, S.; Higashide, T.; Kobayashi, M.; Katsuno, K.; Iyobe, A.; Harada, H.; Sato, F.; Miyata, H.; Asai, H.; Nishimura, A.; Takahira, M.; Souno, T.; Segawa, Y.; Maeda, K.; Shima, K.; Mizuno, A.; Yamamoto, H.; Kawasaki, K. Upregulation of retinal vascular endothelial growth factor mRNAs in spontaneously diabetic rats without ophthalmoscopic retinopathy. A possible participation of advanced glycation end products in the development of the early phase of diabetic retinopathy. Ophthalmic Res., 1998, 30, 333-339.
432. Tolentino, M.J.; Miller, J.W.; Gragoudas, E.S.; Jakobiec, F.A.; Flynn, E.; Chatzistefanou, K.; Ferrara, N.; Adamis, A.P. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology, 1996, 103, 1820-1828.
433. Tolentino, M. J.; McLeod, D. S.; Taomoto, M.; Otsuji, T.; Adamis, A. P.; Lutty, G. A. Pathologic features of vascular endothelial growth factor-induced retinopathy in the nonhuman primate. Am. J. Ophthalmol., 2002, 133, 373-385.
434. Arevalo, J.F.; Fromow-Guerra, J.; Quiroz-Mercado, H.; Sanchez, J.G.; Wu, L.; Maia, M.; Berrocal, M.H.; Solis-Vivanco, A.; Farah, M.E.; Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology, 2007, 114, 743-750.
435. Starita, C.; Patel, M.; Katz, B.; Adamis, A. P. Vascular endothelial growth factor and the potential therapeutic use of pegaptanib (macugen) in diabetic retinopathy. Dev. Ophthalmol., 2007, 39, 122-148.
436. Kowluru, R. A.; Odenbach, S. Role of interleukin-1beta in the development of retinopathy in rats: effect of antioxidants. Invest. Ophthalmol. Vis. Sci., 2004, 45, 4161-4166.
437. Vincent, J. A.; Mohr, S. Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia. Diabetes, 2007, 56, 224-230.
438. Mohr, S.; Xi, X.; Tang, J.; Kern, T. S. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes, 2002, 51, 1172-1179.
439. Harada, C.; Okumura, A.; Namekata, K.; Nakamura, K.; Mitamura, Y.; Ohguro, H.; Harada, T. Role of monocyte chemotactic protein-1 and nuclear factor kappa B in the pathogenesis of proliferative diabetic retinopathy. Diabetes Res. Clin. Pract., 2006, 74, 249-256.
440. Zhang, J.; Gerhardinger, C.; Lorenzi, M. Early complement activation and decreased levels of glycosylphosphatidylinositolanchored complement inhibitors in human and experimental diabetic retinopathy. Diabetes, 2002, 51, 3499-3504.
441. Davies, C. S.; Harris, C. L.; Morgan, B. P. Glycation of CD59 impairs complement regulation on erythrocytes from diabetic subjects. Immunology, 2005, 114, 280-286.
442. Qin, X.; Goldfine, A.; Krumrei, N.; Grubissich, L.; Acosta, J.; Chorev, M.; Hays, A.P.; Halperin, J.A. Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes. Diabetes, 2004, 53, 2653-2661.